<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Little quantitative data exist on the extent of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (genetically-mediated cell deletion) in different human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="1" ids="51686">Hematoxylin</z:chebi> and eosin-stained paraffin sections of 102 <z:mp ids='MP_0002018'>malignant tumors</z:mp> (58 types) were evaluated for apoptotic cells and apoptotic bodies, using the 40x objective with a calibrated eye-piece and avoiding necrotic zones </plain></SENT>
<SENT sid="2" pm="."><plain>The percentage of apoptotic cells and apoptotic bodies in the total number of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells examined was designated as the apoptotic index (AI) for each case </plain></SENT>
<SENT sid="3" pm="."><plain>There was a wide range in the AI for different <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types: 45 tumors had AI &lt; 1% and 93 had an AI of &lt; 7% </plain></SENT>
<SENT sid="4" pm="."><plain>In 107 additional <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (11 types), the AI was determined to be within the same low, intermediate, or high range as the index cases </plain></SENT>
<SENT sid="5" pm="."><plain>Apoptotic nuclear material was usually more prominent than mitoses </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that each <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type has a characteristic AI that reflects innate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell susceptibility to undergo <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Additional data are needed to determine whether significant variations in AI correlate with altered proliferative indices, aberrant oncogene/<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene expression, and standard clinicopathologic variables </plain></SENT>
</text></document>